<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03938948</url>
  </required_header>
  <id_info>
    <org_study_id>COH02.01</org_study_id>
    <nct_id>NCT03938948</nct_id>
  </id_info>
  <brief_title>Low Level Light Therapy (LLLT) for Hair Growth</brief_title>
  <official_title>The Efficacy of Visible Red Light for Promoting the Growth of Human Scalp Hair for Both Male and Female - An Open-label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Awareable Technologies Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Awareable Technologies Inc</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A total of 62 participants will receive red light (660 nm) to the scalp through a specially
      designed light therapy device integrated into a conventional hat. Each treatment will be 30
      min per session applied on every other day for 14 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hair Density</measure>
    <time_frame>14 weeks</time_frame>
    <description>Individual participant's hair density will be measured at the end of 14 weeks and compared with the baseline density measure at the start of the treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hair Density</measure>
    <time_frame>14 weeks</time_frame>
    <description>Mean hair density for the participants after 14 weeks will be compiled and compared with the mean density of the participants' at the start of the study to determine changes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hair Follicle Change</measure>
    <time_frame>14 weeks</time_frame>
    <description>Both individual and all participants' follicles shall be analyzed to determine the percent of change in hair follicle anagen/telogen ratio</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Male Pattern Baldness</condition>
  <condition>Female Pattern Baldness</condition>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>62 participants shall be enrolled</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>low-level laser/light therapy</intervention_name>
    <description>Participants will wear light therapy devices for 14 weeks</description>
    <arm_group_label>Treatment Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects between the ages of 18 and 60 years

          -  Diagnosed AGA in the past 12 months for male (Fitzpatrick I-IV, Hamilton-Norwood IIa-V
             ) and female (Fitzpatrick I-IV, and Ludwig-Savin Baldness Scale I-2, I-3, I-4, II-1,
             II-2 baldness patterns)

        Exclusion Criteria:

          -  Known Photosensitivity

          -  Using any oral or topical substance for hair growth

          -  Having Tattoo, hair transplantation, scalp reduction, malignancy or hair weave in the
             scalp are with alopecia

          -  Known medical conditions that could negatively affect hair growth, such as infections,
             connective tissue disease

          -  Currently or plan to be on a calorie-restricted diet during study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Will, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Elinor Chang</last_name>
    <phone>6507282300</phone>
    <phone_ext>813</phone_ext>
    <email>zmz998100@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Will Surgical Arts</name>
      <address>
        <city>Ijamsville</city>
        <state>Maryland</state>
        <zip>21754</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Redke</last_name>
      <phone>301-874-1707</phone>
      <email>tina@willsurgicalarts.com</email>
    </contact>
    <contact_backup>
      <last_name>J</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>May 3, 2019</last_update_submitted>
  <last_update_submitted_qc>May 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

